SYNJ2BP and neoplasm: In breast cancer, SUMOylation of the fusion protein Synaptojanin 2 binding protein-Cytochrome-c oxidase 16 (SYNJ2BP-COX16) promotes tumor progression via phosphorylating DRP1 and increasing mitochondrial fission [14].